1369 CIS-demasking cytokine linker technology allows selective cytokine delivery to activated immune cells while sparing others and peripheral toxicity
Main Authors: | Caroline Mary, Géraldine Teppaz, Virginie Thépénier, Nicolas Poirier, Aurore morello, Margaux Seite, Justine Durand, Cecile Batty, Julien Taurelle, Amandine Georges |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
852 Modified-epitope-based vaccine (OSE2101) combined with anti-PD-1/IL-7v bispecific antibody sustains long-lasting tumor specific antigen memory T cell response in vivo
by: Caroline Mary, et al.
Published: (2023-11-01) -
1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy
by: Caroline Mary, et al.
Published: (2023-11-01) -
Aerosol demasking enhances climate warming over South Asia
by: H. R. C. R. Nair, et al.
Published: (2023-05-01) -
Sodium dithionite as a selective demasking agent for the complexometric determination of thallium
by: Shetty Prakash, et al.
Published: (2005-01-01) -
Sodium dithionite as a selective demasking agent for the complexometric determination of thallium
by: PRAKASH SHETTY, et al.
Published: (2005-11-01)